[Commentary to the articles: Kaplan NM. Vascular outcome in type 2 diabetes: an ADVANCE? Lancet 2007; 370:804-5; Patel A; ADVANCE Collaborative Group,...

Keywords

MedicineOutcome (game theory)Type 2 diabetesGroup (periodic table)GerontologyInternal medicineDiabetes mellitusEndocrinologyMathematical economicsQuantum mechanics

Related Publications

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic , Meg Jardine , Bruce Neal +21 more

In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...

2019 New England Journal of Medicine 5513 citations

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray , Scott D. Solomon , Silvio E. Inzucchi +35 more

BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through ...

2019 New England Journal of Medicine 6238 citations

Publication Info

Year: 2007
Type: article
Volume: 65
Issue: 12
Pages: 1527-9; discussion 1530
Citations: 265
Access: Closed

External Links

Citation Metrics

265

OpenAlex

Cite This

APA Style

                            
                                    Anna Szyndler
                                
                            (2007). 
                            [Commentary to the articles: Kaplan NM. Vascular outcome in type 2 diabetes: an ADVANCE? Lancet 2007; 370:804-5; Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B i wsp. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370:829-40].. 
                            PubMed
                            , 65
                            (12)
                            , 1527-9; discussion 1530.